GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (STU:1FX) » Definitions » Sale Of Investment

Ananda Pharma (STU:1FX) Sale Of Investment : €0.00 Mil (TTM As of Jul. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Ananda Pharma Sale Of Investment?

Ananda Pharma's sale of investment for the six months ended in Jul. 2024 was €0.00 Mil. It means Ananda Pharma gained €0.00 Mil from selling investments. Ananda Pharma's sale of investment for the trailing twelve months (TTM) ended in Jul. 2024 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Jul. 2023 ), Ananda Pharma gained the same money from selling investments in Jul. 2024 (€0.00 Mil).


Ananda Pharma Sale Of Investment Historical Data

The historical data trend for Ananda Pharma's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma Sale Of Investment Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
Sale Of Investment
- - - - -

Ananda Pharma Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jul24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ananda Pharma Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Jul. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ananda Pharma Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Pharma Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.

Ananda Pharma Headlines

No Headlines